Respiratory Virus Nasal Spray
Clinical Trial
What is your age?
Compensation Up To $1,800
Generally healthy adults between 18 and 45 years old who are at increased risk of exposure to respiratory viruses may qualify for this study of an investigational nasal spray for respiratory viruses.
Qualified participants may receive:
This study is evaluating the safety, tolerability, and effectiveness a once-weekly nasal spray, in preventing symptomatic illness caused by respiratory virus infections. The study targets generally healthy adults at increased risk of viral respiratory exposure due to their living or working environments.
Study Details
| Sex | Male or Female |
|---|---|
| Age | 18-45 |
| Eligibility | Generally healthy adults aged 18-45 at increased risk of exposure to respiratory viruses due to occupation or living conditions |
| Symptoms | At risk for respiratory virus infections such as cold, flu, or similar illnesses |
Respiratory Virus trials in your area can pay up to $1,800 in potential compensation for time and travel.
Why Participate in
Clinical Trials
Clinical trials may give you access to cutting edge treatments & new medications that are currently unavailable elsewhere (free of charge!). As part of trials you are likely to get medical care and more frequent health check-ups. The researchers involved in clinical trials are also often leading experts who have a deep understanding of your condition.
Latest
Treatments
Local
Trials
Potential
Compensation
Health Insurance
Not Required
About Us
GoodLab is a free clinical trial matchmaking service. We partner with a broad range of clinical trial providers across the US to deliver access to cutting-edge treatments & new medications unavailable elsewhere — entirely free of charge.
The trials on our platform don't require you to have insurance - this may assist you in getting quality medical care and greater understanding of your disease.